Changes in brain catecholamines and dopamine uptake sites at different stages of MPTP parkinsonism in monkeys
- 21 August 1992
- journal article
- Published by Elsevier in Brain Research
- Vol. 588 (2) , 261-269
- https://doi.org/10.1016/0006-8993(92)91584-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Dopamine receptor changes in untreated and (+)-PHNO-treated MPTP parkinsonian primatesBrain Research, 1991
- Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. II. Unilateral intra-carotid infusion of MPTP in the monkey (Macaca fascicularis)Brain Research, 1990
- Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSFBrain Research, 1987
- Evidence for neuromelanin involvement in MPTP-induced neurotoxicityNature, 1987
- Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeysAnnals of Neurology, 1986
- Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)Neurology, 1985
- Differential visualization of dopamine and norepinephrine uptake sites in rat brain using [3H]mazindol autoradiographyJournal of Neuroscience, 1985
- III. Primate model of parkinsonism: Selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeysLife Sciences, 1985
- Quantitative computer analysis of autoradiographs utilizing a charge-coupled device solid-state cameraJournal of Neuroscience Methods, 1984
- Parkinsonism Induced By 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP): Implications for Treatment and the Pathogenesis of Parkinson’s DiseaseCanadian Journal of Neurological Sciences, 1984